Empagliflozin Attenuates Diabetic Cardiomyopathy via Inhibiting Cardiomyocyte Ferroptosis Through the USP7/NRF2 Signaling Pathway.

已取消 10 由蟹黄发布于 2026/5/9 14:58:58

DOI:10.1177/15230864251377765
作者：Min Cui,?Junwei Zhang,?Ziwei Wang,?Xiandu Jin,?Hanmo Zhang,?Shengzheng Zhang,?Wenjun Jia,?Hao Wu,?Zhi Qi,?Xin Qi
文献类型：期刊论文
补充材料：只需要正文

Sage

Abstract：Aims: Diabetic cardiomyopathy (DbCM) typically manifests as diastolic dysfunction, and treating heart failure with preserved ejection fraction (HFpEF) is challenging. Empagliflozin (Empa), a

应助信息

1天前

Book学术机器人

2026/5/9 14:58:58 未找到该文献，机器人已退出，请等待人工下载

2026/5/9 14:58:58 Book学术AI机器人收到请求，开始寻找文献

2026/5/9 14:58:58 已向机器人发送请求

1天前

蟹黄发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Wolters Kluwer OvidRole of LPC 18:1 in the Lipid Metabolic Response to Combined Vitamin D and Resistance Exercise for Protecting Diabetic Skeletal Muscle Function.